Evaluation and treatment of erectile dysfunction in the aging Male: A mini-review

Gerontology

Volumn 58, Issue 1, 2011, Pages 3-14

  Albersen, Maarten ^a,b   Orabi, Hazem ^a,c   Lue, Tom F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c Assiut University Faculty of Medicine   (Egypt)

Author keywords

Aging male; Erectile dysfunction; Pathophysiology; Penis; Phosphodiesterase 5 inhibitors

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; APOMORPHINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; ICARIIN; LOSARTAN; MIRODENAFIL; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PAPAVERINE; PHENTOLAMINE; PHENYLEPHRINE; PHOSPHODIESTERASE V INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; TADALAFIL; THIAZIDE DIURETIC AGENT; UDENAFIL; UNINDEXED DRUG; VALSARTAN; VARDENAFIL; VASOACTIVE INTESTINAL POLYPEPTIDE; YOHIMBINE;

AGING; ANXIETY DISORDER; BACKACHE; BLURRED VISION; CIGARETTE SMOKING; CLINICAL ASSESSMENT; COMORBIDITY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; FACIAL FLUSHING; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; MYALGIA; NAUSEA; NEUROTRANSMITTER RELEASE; NOSE CONGESTION; OBESITY; PAINFUL ERECTION; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PENILE BLOOD FLOW; PENILE FIBROSIS; PEYRONIE DISEASE; POLYPHARMACY; PREMATURE EJACULATION; PREVALENCE; PRIAPISM; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SEDENTARY LIFESTYLE; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL SATISFACTION; SEXUALITY; SMOOTH MUSCLE; SMOOTH MUSCLE RELAXATION; SYNCOPE; TACHYCARDIA; URETHRAL BURNING; URETHRAL PAIN; VACUUM; VAGINAL IRRITATION;

AGED; AGED, 80 AND OVER; AGING; APOMORPHINE; ERECTILE DYSFUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; PLANT PREPARATIONS; PROSTHESES AND IMPLANTS; VACUUM;

EID: 84155167230     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000329598     Document Type: Review

References (48)

1. Lindau ST, Schumm LP, Laumann EO, Levinson W, O'Muircheartaigh CA, Waite LJ: A study of sexuality and health among older adults in the United States. N Engl J Med 2007; 357: 762-774. (Pubitemid 47295643)
2. Smith LJ, Mulhall JP, Deveci S, Monaghan N, Reid MC: Sex after seventy: A pilot study of sexual function in older persons. J Sex Med 2007; 4: 1247-1253. (Pubitemid 47337668)
3. NIH Consensus Conference: Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83-90.
4. Uckert S, Mayer ME, Stief CG, Jonas U: The future of the oral pharmacotherapy of male erectile dysfunction: Things to come. Expert Opin Emerg Drugs 2007; 12: 219-228. (Pubitemid 46953563)
5. Hatzimouratidis K, Hatzichristou DG: A comparative review of the options for treatment of erectile dysfunction: Which treatment for which patient? Drugs 2005; 65: 1621-1650. (Pubitemid 41138985)
6. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB: Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study. J Urol 1994; 151: 54-61. (Pubitemid 24046934)
7. Corona G, Lee DM, Forti G, O'Connor DB, Maggi M, O'Neill TW, et al: Age-related changes in general and sexual health in middle-Aged and older men: Results from the European Male Ageing Study (EMAS). J Sex Med 2010; 7: 1362-1380.
8. Russell ST, Khandheria BK, Nehra A: Erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2004; 79: 782-794. (Pubitemid 38691830)
9. Albersen M, Shindel AW, Lue TF: Sexual dysfunction in the older man. Rev Clin Gerontol 2009; 19: 237-248.
10. Ayta IA, McKinlay JB, Krane RJ: The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50-56.
11. Laumann EO, Waite LJ: Sexual dysfunction among older adults: Prevalence and risk factors from a nationally representative US probability sample of men and women 57-85 years of age. J Sex Med 2008; 5: 2300-2311.
12. Saigal CS, Wessells H, Pace J, Schonlau M, Wilt TJ: Urologic Diseases in America Project. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 2006; 166: 207-212. (Pubitemid 43144945)
13. Lue TF: Erectile dysfunction. N Engl J Med 2000; 342: 1802-1813. (Pubitemid 30390241)
14. Albersen M, Shindel AW, Mwamukonda KB, Lue TF: The future is today: Emerging drugs for the treatment of erectile dysfunction. Expert Opin Emerg Drugs 2010; 15: 467-480.
15. Hannan JL, Blaser MC, Oldfield L, Pang JJ, Adams SM, Pang SC, et al: Morphological and functional evidence for the contribution of the pudendal artery in aging-induced erectile dysfunction. J Sex Med 2010; 7: 3373-3384.
16. El-Sakka AI, Yassin AA: Amelioration of penile fibrosis: Myth or reality. J Androl 2010; 31: 324-335.
17. Rudner XL, Berkowitz DE, Booth JV, Funk BL, Cozart KL, D'Amico EB, El-Moalem H, Page SO, Richardson CD, Winters B, Marucci L, Schwinn DA: Subtype specific regulation of human vascular alpha(1)-adrenergic receptors by vessel bed and age. Circulation 1999; 100: 2336-2343.
18. Christ GJ, Stone B, Melman A: Age-dependent alterations in the efficacy of phenylephrine- induced contractions in vascular smooth muscle isolated from the corpus cavernosum of impotent men. Can J Physiol Pharmacol 1991; 69: 909-913.
19. Vanhoutte PM: Ageing and endothelial dysfunction. Eur Heart J Suppl 2002; 4(suppl A):A8-A17.
20. Musicki B, Kramer MF, Becker RE, Burnett AL: Age-related changes in phosphorylation of endothelial nitric oxide synthase in the rat penis. J Sex Med 2005; 2: 347-355.
21. Aversa A, Bruzziches R, Francomano D, Natali M, Gareri P, Spera G: Endothelial dysfunction and erectile dysfunction in the aging man. Int J Urol 2010; 17: 38-47.
22. Park CS, Ryu SD, Hwang SY: Elevation of intracavernous pressure and NO-cGMP activity by a new herbal formula in penile tissues of aged and diabetic rats. J Ethnopharmacol 2004; 94: 85-92.
23. Wespes E: The ageing penis. World J Urol 2002; 20: 36-39.
24. Ferrini MG, Davila HH, Valente EG, Gonzalez- Cadavid NF, Rajfer J: Aging-related induction of inducible nitric oxide synthase is vasculo-protective to the arterial media. Cardiovasc Res 2004; 61: 796-805. (Pubitemid 38249479)
25. Ferrini M, Magee TR, Vernet D, Rajfer J, Gonzalez-Cadavid NF: Aging-related expression of inducible nitric oxide synthase and markers of tissue damage in the rat penis. Biol Reprod 2001; 64: 974-982. (Pubitemid 32174071)
26. Traish AM, Munarriz R, O'Connell L, Choi S, Kim SW, Kim NN, et al: Effects of medical or surgical castration on erectile function in an animal model. J Androl 2003; 24: 381-387. (Pubitemid 39571794)
27. Rogers RS, Graziottin TM, Lin CS, Kan YW, Lue TF: Intracavernosal vascular endothelial growth factor (VEGF) injection and adenoassociated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res 2003; 15: 26-37. (Pubitemid 36356356)
28. Traish A, Kim N: The physiological role of androgens in penile erection: Regulation of corpus cavernosum structure and function. J Sex Med 2005; 2: 759-770. (Pubitemid 41727389)
29. Traish AM, Kim N: Weapons of penile smooth muscle destruction: Androgen deficiency promotes accumulation of adipocytes in the corpus cavernosum. Aging Male 2005; 8: 141-146. (Pubitemid 43068302)
30. Lue TF, Broderick GA: Evaluation and nonsurgical management of erectile dysfunction and premature ejaculation; in Campbell- Walsh Urology ed 9. Amsterdam, Elsevier, 2007.
31. Jackson G, Rosen RC, Kloner RA, Kostis JB: The second Princeton consensus on sexual dysfunction and cardiac risk: New guidelines for sexual medicine. J Sex Med 2006; 3: 28-36.
32. Korfage IJ, Pluijm S, Roobol M, Dohle GR, Schroder FH, Essink-Bot ML: Erectile dysfunction and mental health in a general population of older men. J Sex Med 2009; 6: 505-512.
33. Saltzman EA, Guay AT, Jacobson J: Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: A clinical observation. J Urol 2004; 172: 255-258.
34. Montejo-Gonzalez AL, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, et al: SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997; 23: 176-194. (Pubitemid 27514710)
35. Rosen RC, Lane RM, Menza M: Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol 1999; 19: 67-85. (Pubitemid 29047334)
36. Fujisawa M, Sawada K: Clinical efficacy and safety of sildenafil in elderly patients with erectile dysfunction. Arch Androl 2004; 50: 255-260. (Pubitemid 38858390)
37. Bella AJ, Deyoung LX, Al-Numi M, Brock GB: Daily administration of phosphodiesterase type 5 inhibitors for urological and nonurological indications. Eur Urol 2007; 52: 990-1005. (Pubitemid 47334787)
38. Shindel AW: Update on phosphodiesterase type 5 inhibitor therapy part 1: Recent studies on routine dosing for penile rehabilitation, lower urinary tract symptoms, and other indications (CME). J Sex Med 2009; 6: 1794-1808.
39. Konstantinopoulos A, Giannitsas K, Athanasopoulos A, Spathas D, Perimenis P: The impact of daily sildenafil on levels of soluble molecular markers of endothelial function in plasma in patients with erectile dysfunction. Expert Opin Pharmacother 2009; 10: 155-160.
40. Shabsigh R, Kaufman JM, Steidle C, Padma- Nathan H: Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 2004; 172: 658-663. (Pubitemid 38900229)
41. Giuliano F, Donatucci C, Montorsi F, Auerbach S, Karlin G, Norenberg C, et al: Vardenafil is effective and well-tolerated for treating erectile dysfunction in a broad population of men, irrespective of age. BJU Int 2005; 95: 110-116. (Pubitemid 350027199)
42. Brock GB, McMahon CG, Chen KK, Costigan T, Shen W, Watkins V, et al: Efficacy and safety of tadalafil for the treatment of erectile dysfunction: Results of integrated analyses. J Urol 2002; 168: 1332-1336. (Pubitemid 35034115)
43. Hatzimouratidis K, Hatzichristou D: Phosphodiesterase type 5 inhibitors: The day after. Eur Urol 2007; 51: 75-88.
44. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, et al: Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur Urol 2010; 57: 804-814.
45. Ning H, Xin ZC, Lin G, Banie L, Lue TF, Lin CS: Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology 2006; 68: 1350-1354. (Pubitemid 44880379)
46. Shindel AW, Xin ZC, Lin G, Fandel TM, Huang YC, Banie L, et al: Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo. J Sex Med 2010; 7: 1518-1528.
47. Jones RW, Rees RW, Minhas S, Ralph D, Persad RA, Jeremy JY: Oxygen free radicals and the penis. Expert Opin Pharmacother 2002; 3: 889-897. (Pubitemid 34752507)
48. Hellstrom WJ, Montague DK, Moncada I, Carson C, Minhas S, Faria G, et al: Implants, mechanical devices, and vascular surgery for erectile dysfunction. J Sex Med 2010; 7: 501-523.